Pregnant women may receive critical treatment sooner with help of fast and easy test
About one in 20 women develop preeclampsia during pregnancy, which can be life-threatening to both moms and babies. However, it is difficult to diagnose because symptoms often mimic those of a normal pregnancy, such as swelling and headaches. Managing the condition early is critical to keeping mother and child safe, and now a new innovation may help start treatment sooner by quickly identifying preeclampsia with a simple urine test. In a new study, researchers at The Ohio State University Wexner Medical Center tested a fast and easy test to accurately diagnose the condition in just three minutes.
“Giving birth is the only cure for preeclampsia, but it can develop as early as the second trimester,” said Dr. Kara Rood, lead author of the study and maternal-fetal medicine physician at Ohio State Wexner Medical Center. “The quicker we identify women with the condition, the better chance they have of carrying their babies to full term and having a healthy delivery.”
The test uses a special red dye that reacts to unique proteins in the urine of pregnant women with preeclampsia. It can be given easily during a prenatal visit, providing an immediate diagnosis. “Without the certainty of this test, providers tend to be overcautious because this is definitely a condition that we can’t allow to go untreated,” said Rood. “This test helps us to quickly provide care to women with preeclampsia, while avoiding unnecessary admissions or even early deliveries.”
Researchers expect the new rapid test to be FDA approved in the next few years so that OB/GYNs nationwide can use it to identify cases of preeclampsia. Dr. Rood hopes it will also be available for women to use at home to monitor complications during pregnancy.
The Latest on: Preeclampsia
via Google News
The Latest on: Preeclampsia
- Ninety placentas provide clues to preeclampsia (image)on January 21, 2021 at 9:11 am
The results of many years of research have been a long time coming. Gabriela Silva (in the white labocoat) used tissue samples from a biobank, including placenta samples from 90 women with ...
- Researchers discover Important Cause Of Preeclampsiaon January 21, 2021 at 8:39 am
Despite being the subject of increasing interest for a whole century, how preeclampsia develops has been unclear - until now.
- Important cause of preeclampsia discoveredon January 21, 2021 at 6:32 am
Despite being the subject of increasing interest for a whole century, how preeclampsia develops has been unclear—until now.
- Preeclampsia Diagnostics Market Worth USD 2.52 Billion at 11.0% CAGR; Increasing Healthcare Expenditure to Boost Growth: Fortune Business Insights™on January 21, 2021 at 4:13 am
The global preeclampsia diagnostics market size is anticipated to gain momentum from the increasing number of pregnancies ...
- Preeclampsia Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecaston January 20, 2021 at 11:59 am
DelveInsight's Preeclampsia Market Insights, Epidemiology, and Market Forecast 2030 report delivers an in-depth understanding of the Preeclampsia, historical and forecasted epidemiology as well as the ...
- Mom Who Gave Birth While Hospitalized with COVID-19 Gets Lung Transplant: 'One Hell of a Fighter'on January 19, 2021 at 4:50 pm
"She’s a loving wife, mom, daughter, friend and so much more," Ricky Dennis said of his wife, Jackie, who is battling coronavirus ...
- Preeclampsia Revisitedon January 18, 2021 at 4:00 pm
Without clear national consensus guidelines on the origin of preeclampsia, the clinician is faced with management challenges and maternal and fetal risk-versus-benefit issues. The key to ...
- Fetal-maternal discordance in APOL1 genotype contributes to preeclampsia riskon January 12, 2021 at 12:50 pm
IMAGE: Fetal APOL1 kidney risk alleles are associated with increased risk for preeclampsia in African Americans and maternal fetal genotype discordance is also associated with this risk view more ...
- Hypertension in Pregnancy Tied to Later Cognitive Impairmenton January 12, 2021 at 9:14 am
Compared with those who had normal blood pressure during pregnancy, women who developed gestational hypertension or preeclampsia performed worse on immediate and delayed recall testing a median of ...
- Glenveigh Medical Announces Orphan Drug Designation For Treatment For Severe Preeclampsia & Eclampsiaon January 11, 2021 at 4:00 pm
Glenveigh Medical announced Tuesday that the U.S. Food and Drug Administration has granted its request for orphan drug designation for a potential new therapy to treat severe preeclampsia and ...
via Bing News